Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial (Q44026235)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial |
scientific article |
Statements
1 reference
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial (English)
1 reference
E Heidemann
1 reference
H Stoeger
1 reference
R Souchon
1 reference
W-D Hirschmann
1 reference
H Bodenstein
1 reference
C Oberhoff
1 reference
J T Fischer
1 reference
M Schulze
1 reference
M Clemens
1 reference
R Andreesen
1 reference
M Mahlke
1 reference
M König
1 reference
A Scharl
1 reference
K Fehnle
1 reference
M Kaufmann
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference